Bought
Maintained
Sold
Other funds holding ZLAB
WP
RSCM
Aviva's ZLAB Position: Q2 2024 in Review
Aviva sold out of Zai Lab (ZLAB) in Q2 2024, closing a stake of 59,330 shares — an estimated $950K sold.
Aviva first reported a position in ZLAB in Q1 2020 and held it in 17 quarters. The position peaked at $3.96M in Q2 2021. 105 funds tracked by Wall St. Rank hold ZLAB as of Q2 2024.
- Aviva reported no remaining Zai Lab position as of Q2 2024 after selling out during the quarter.
- Aviva sold 59,330 Zai Lab shares in Q2 2024, an estimated $950K.
- Aviva first reported a position in Zai Lab in Q1 2020 and held it in 17 quarters.
- Aviva's Zai Lab position peaked at $3.96M in Q2 2021.
- 105 funds tracked by Wall St. Rank held Zai Lab as of Q2 2024.
Based on Aviva's 13F filing for Q2 2024, filed 2 Aug 2024.